secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001213900-23-069983
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Biotech CEO resigns; interim CEO appointed; Audit Committee reviews employee expenditures
--------------------------------------------------------------------------------

- Joseph Hernandez resigned as Chairman, CEO, and Board member, effective Aug 16, 2023.
- James Sapirstein appointed Interim Executive Chairman effective Sept 30; receives $25k/month.
- CFO Jon Garfield appointed interim principal executive officer until Sapirstein's appointment.
- Audit Committee commenced independent review of company employee expenditures and classification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023069983/0001213900-23-069983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023069983/ea184059-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-069983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer